Course Description
| Course | Code | Semester | T+P (Hour) | Credit | ECTS |
|---|---|---|---|---|---|
| CLINICAL PHARMACY in INTENSIVE CARE UNIT | - | Fall Semester | 2+0 | 2 | 12 |
| Course Program |
| Prerequisites Courses | |
| Recommended Elective Courses |
| Language of Course | Turkish |
| Course Level | Third Cycle (Doctorate Degree) |
| Course Type | Elective |
| Course Coordinator | Assist.Prof. Büşra Nur ÇATTIK |
| Name of Lecturer(s) | Assoc.Prof. Cem ERDOĞAN, Assist.Prof. Deniz KIZILASLAN |
| Assistant(s) | |
| Aim | Evaluation of the role of the clinical pharmacist in the management of the treatment of the patients in the intensive care unit. |
| Course Content | This course contains; Patient follow-up in the intensive care unit,Nutrition in the intensive care unit,Local anesthetics in the intensive care unit,Intravenous anesthetics in the intensive care unit,Neuromuscular blockers in the intensive care unit,Dehydration treatment in the intensive care unit,Oxygen therapy in the intensive care unit,Delirium treatment in the intensive care unit,Drugs affecting the central nervous system in the intensive care unit,Drug interactions in the intensive care unit,Case discussion in the intensive care unit I,Case discussion in the intensive care unit II,Case discussion in the intensive care unit III,Case discussion in the intensive care unit IV. |
| Dersin Öğrenme Kazanımları | Teaching Methods | Assessment Methods |
| 1. Performs patient follow-up in the intensive care unit. | 11, 12, 14, 2, 3, 4 | A, E |
| 2. Discuss nutritional management in the intensive care unit. | 11, 12, 14, 2, 3, 4 | A, E |
| 3. Discuss the use of local anesthetics in the intensive care unit. | 11, 12, 14, 2, 3, 4 | A, E |
| 4. Discuss the use of intravenous anesthetics in the intensive care unit. | 11, 12, 14, 2, 3, 4 | A, E |
| 5. Discuss the use of neuromuscular blockers in the intensive care unit. | 11, 12, 14, 2, 3, 4 | A, E |
| 6. Analyzes dehydration treatment management in the intensive care unit. | 11, 12, 14, 2, 4 | A, E |
| 7. Analyzes oxygen therapy requirements in the intensive care unit. | 11, 12, 14, 2, 3, 4 | A, E |
| 8. Discuss delirium treatment management in the intensive care unit. | 11, 12, 14, 2, 3, 4 | A, E |
| 9. Discuss the use of drugs that affect the central nervous system in the intensive care unit. | 11, 12, 14, 2, 3, 4 | A, E |
| 10. Analyzes drug interactions in the intensive care unit. | 11, 12, 14, 18, 2, 3, 4 | A, E |
| 11. Analyzes the management of real cases in the intensive care unit. | 11, 12, 14, 2, 3 | A, E |
| 12. Discuss the diagnosis and treatment strategy of the case in the intensive care unit. | 11, 12, 14, 2, 3, 4 | A, E |
| 13. Discuss the follow-up of patients and management of treatment processes in the intensive care unit. | 11, 12, 14, 2, 3, 4 | A, E |
| 14. Monitors and analyzes the effects of drug treatments in the intensive care unit. | 14, 2, 3, 4 | A, E |
| 15. Analyzes and discusses important issues regarding patient safety and quality of care in the intensive care unit. | 11, 12, 14, 2, 3, 4 | A, E |
| Teaching Methods: | 11: Demonstration Method, 12: Problem Solving Method, 14: Self Study Method, 18: Micro Teaching Technique, 2: Project Based Learning Model, 3: Problem Baded Learning Model, 4: Inquiry-Based Learning |
| Assessment Methods: | A: Traditional Written Exam, E: Homework |
Course Outline
| Order | Subjects | Preliminary Work |
|---|---|---|
| 1 | Patient follow-up in the intensive care unit | 1, 2, 3 |
| 2 | Nutrition in the intensive care unit | 1, 2, 3 |
| 3 | Local anesthetics in the intensive care unit | 1, 2, 3 |
| 4 | Intravenous anesthetics in the intensive care unit | 1, 2, 3 |
| 5 | Neuromuscular blockers in the intensive care unit | 1, 2, 3 |
| 6 | Dehydration treatment in the intensive care unit | 1, 2, 3 |
| 7 | Oxygen therapy in the intensive care unit | 1, 2, 3 |
| 8 | Delirium treatment in the intensive care unit | 1, 2, 3 |
| 9 | Drugs affecting the central nervous system in the intensive care unit | 1, 2, 3 |
| 10 | Drug interactions in the intensive care unit | 1, 2, 3 |
| 11 | Case discussion in the intensive care unit I | 1, 2, 3 |
| 12 | Case discussion in the intensive care unit II | 1, 2, 3 |
| 13 | Case discussion in the intensive care unit III | 1, 2, 3 |
| 14 | Case discussion in the intensive care unit IV | 1, 2, 3 |
| Resources |
| 1. Lecture notes 2. E-book: Wells BG (2015) Pharmacotherapy handbook (9th ed), McGraw-Hill 3. scientific article databases (www.pubmed.com) |
Course Contribution to Program Qualifications
| Course Contribution to Program Qualifications | |||||||
| No | Program Qualification | Contribution Level | |||||
| 1 | 2 | 3 | 4 | 5 | |||
| 1 | PY-1.Develops, deepens and deepens innovation in the fields of Clinical pharmacy based on master's qualifications with original thought and research at the level of expertise. | X | |||||
| 2 | PY-2.Interdisciplinary interaction with the field is related to; Reaching original results by using knowledge that requires expertise in analyzing, synthesizing and evaluating new and complex ideas. | X | |||||
| 3 | PY-3.Has advanced knowledge about the other technological tools including computer and the devices and tools which are specific to the field at the level required by the field. | ||||||
| 4 | PY-4.Has knowledge about statistical methods. Evaluates and uses new information in the field with a systematic approach. | ||||||
| 5 | PY-5. Has the advanced knowledge of creating patient profiles, patient education, and medication counseling. | X | |||||
| 6 | PY-6.Write the report of the researcher / participant. National / internationally accepted publications are published at scientific meetings. | X | |||||
| 7 | PY-7.Performs necessary examinations using other technological tools including computer and the devices and tools specific to the field at the advanced level as required by the field; Develop new creative solutions to problems. | ||||||
| 8 | PY-8.Develop a new idea, method, design or practice that brings innovation to the field, or researches, designs, adapts and applies a known idea, method, design or application that applies to a different field. | X | |||||
| 9 | PY-9. Uses the knowledge and equipment related to administering medicine to patients and the use of the drug. Gives pharmaceutical care service by providing rational and safe drug use with the duty of observance and supervision. | X | |||||
| 10 | PY-10. Acquires administrative and technical stand-by equipment in the areas where the clinical pharmacy is responsible for and achieves hospital pharmacy practices properly. | X | |||||
| 11 | PY-11.Develop new ideas and methods related to the field by using high level mental processes such as creative and critical thinking, problem solving and decision making. | X | |||||
| 12 | PY-12. Demonstrates embarking on lifelong learning, open for improvement, and continue this behavior. | X | |||||
| 13 | PY-13.Selects the correct statistical methods in the field of health care work and applies and interprets. | ||||||
| 14 | PY-14. Has sufficient consciousness in the field of individual and public health, environmental protection, and job security and applies it. | X | |||||
| 15 | PY-15. Informs relevant persons and institutions in the fields of quality assurance of pharmaceutical products. | ||||||
| 16 | PY-16. Contributes to the solution of scientific, cultural, and ethical problems encountered in the field of clinical pharmacy and corroborates the improvement of these values. Behaves according to the legislation and professional ethics related to duty, right, and responsibilities as an individual. | X | |||||
| 17 | PY-17. Safely documents and keeps track of professional activities and practices. | X | |||||
| 18 | PY-18. Provides information to the patience, healthcare personnel, and society on every drug-related issue. | X | |||||
| 19 | PY-19. Follows and evaluates national and international developments in the field of clinical pharmacy. | X | |||||
| 20 | PY-20.Analyzes statistically to evaluate a scientific article. | ||||||
| 21 | PY-21.Broaden the boundaries of information in the field by publishing at least one scientific article related to the field in national and / or internationally eminent journals. | X | |||||
| 22 | PY-22.Contributes to the advancement of the field by bringing innovation to the field, developing a new idea, method, design or application, or performing an original study independently applying a known idea, method, design or application to a different field. | X | |||||
| 23 | PY-23. Plans, manages, watches the process, and evaluates activities that oriented improvements of employees as part of a project. | X | |||||
Assessment Methods
| Contribution Level | Absolute Evaluation | |
| Rate of Midterm Exam to Success | 50 | |
| Rate of Final Exam to Success | 50 | |
| Total | 100 | |
| ECTS / Workload Table | ||||||
| Activities | Number of | Duration(Hour) | Total Workload(Hour) | |||
| Course Hours | 14 | 2 | 28 | |||
| Guided Problem Solving | 14 | 5 | 70 | |||
| Resolution of Homework Problems and Submission as a Report | 14 | 7 | 98 | |||
| Term Project | 0 | 0 | 0 | |||
| Presentation of Project / Seminar | 14 | 6 | 84 | |||
| Quiz | 0 | 0 | 0 | |||
| Midterm Exam | 7 | 5 | 35 | |||
| General Exam | 7 | 5 | 35 | |||
| Performance Task, Maintenance Plan | 0 | 0 | 0 | |||
| Total Workload(Hour) | 350 | |||||
| Dersin AKTS Kredisi = Toplam İş Yükü (Saat)/30*=(350/30) | 12 | |||||
| ECTS of the course: 30 hours of work is counted as 1 ECTS credit. | ||||||
Detail Informations of the Course
Course Description
| Course | Code | Semester | T+P (Hour) | Credit | ECTS |
|---|---|---|---|---|---|
| CLINICAL PHARMACY in INTENSIVE CARE UNIT | - | Fall Semester | 2+0 | 2 | 12 |
| Course Program |
| Prerequisites Courses | |
| Recommended Elective Courses |
| Language of Course | Turkish |
| Course Level | Third Cycle (Doctorate Degree) |
| Course Type | Elective |
| Course Coordinator | Assist.Prof. Büşra Nur ÇATTIK |
| Name of Lecturer(s) | Assoc.Prof. Cem ERDOĞAN, Assist.Prof. Deniz KIZILASLAN |
| Assistant(s) | |
| Aim | Evaluation of the role of the clinical pharmacist in the management of the treatment of the patients in the intensive care unit. |
| Course Content | This course contains; Patient follow-up in the intensive care unit,Nutrition in the intensive care unit,Local anesthetics in the intensive care unit,Intravenous anesthetics in the intensive care unit,Neuromuscular blockers in the intensive care unit,Dehydration treatment in the intensive care unit,Oxygen therapy in the intensive care unit,Delirium treatment in the intensive care unit,Drugs affecting the central nervous system in the intensive care unit,Drug interactions in the intensive care unit,Case discussion in the intensive care unit I,Case discussion in the intensive care unit II,Case discussion in the intensive care unit III,Case discussion in the intensive care unit IV. |
| Dersin Öğrenme Kazanımları | Teaching Methods | Assessment Methods |
| 1. Performs patient follow-up in the intensive care unit. | 11, 12, 14, 2, 3, 4 | A, E |
| 2. Discuss nutritional management in the intensive care unit. | 11, 12, 14, 2, 3, 4 | A, E |
| 3. Discuss the use of local anesthetics in the intensive care unit. | 11, 12, 14, 2, 3, 4 | A, E |
| 4. Discuss the use of intravenous anesthetics in the intensive care unit. | 11, 12, 14, 2, 3, 4 | A, E |
| 5. Discuss the use of neuromuscular blockers in the intensive care unit. | 11, 12, 14, 2, 3, 4 | A, E |
| 6. Analyzes dehydration treatment management in the intensive care unit. | 11, 12, 14, 2, 4 | A, E |
| 7. Analyzes oxygen therapy requirements in the intensive care unit. | 11, 12, 14, 2, 3, 4 | A, E |
| 8. Discuss delirium treatment management in the intensive care unit. | 11, 12, 14, 2, 3, 4 | A, E |
| 9. Discuss the use of drugs that affect the central nervous system in the intensive care unit. | 11, 12, 14, 2, 3, 4 | A, E |
| 10. Analyzes drug interactions in the intensive care unit. | 11, 12, 14, 18, 2, 3, 4 | A, E |
| 11. Analyzes the management of real cases in the intensive care unit. | 11, 12, 14, 2, 3 | A, E |
| 12. Discuss the diagnosis and treatment strategy of the case in the intensive care unit. | 11, 12, 14, 2, 3, 4 | A, E |
| 13. Discuss the follow-up of patients and management of treatment processes in the intensive care unit. | 11, 12, 14, 2, 3, 4 | A, E |
| 14. Monitors and analyzes the effects of drug treatments in the intensive care unit. | 14, 2, 3, 4 | A, E |
| 15. Analyzes and discusses important issues regarding patient safety and quality of care in the intensive care unit. | 11, 12, 14, 2, 3, 4 | A, E |
| Teaching Methods: | 11: Demonstration Method, 12: Problem Solving Method, 14: Self Study Method, 18: Micro Teaching Technique, 2: Project Based Learning Model, 3: Problem Baded Learning Model, 4: Inquiry-Based Learning |
| Assessment Methods: | A: Traditional Written Exam, E: Homework |
Course Outline
| Order | Subjects | Preliminary Work |
|---|---|---|
| 1 | Patient follow-up in the intensive care unit | 1, 2, 3 |
| 2 | Nutrition in the intensive care unit | 1, 2, 3 |
| 3 | Local anesthetics in the intensive care unit | 1, 2, 3 |
| 4 | Intravenous anesthetics in the intensive care unit | 1, 2, 3 |
| 5 | Neuromuscular blockers in the intensive care unit | 1, 2, 3 |
| 6 | Dehydration treatment in the intensive care unit | 1, 2, 3 |
| 7 | Oxygen therapy in the intensive care unit | 1, 2, 3 |
| 8 | Delirium treatment in the intensive care unit | 1, 2, 3 |
| 9 | Drugs affecting the central nervous system in the intensive care unit | 1, 2, 3 |
| 10 | Drug interactions in the intensive care unit | 1, 2, 3 |
| 11 | Case discussion in the intensive care unit I | 1, 2, 3 |
| 12 | Case discussion in the intensive care unit II | 1, 2, 3 |
| 13 | Case discussion in the intensive care unit III | 1, 2, 3 |
| 14 | Case discussion in the intensive care unit IV | 1, 2, 3 |
| Resources |
| 1. Lecture notes 2. E-book: Wells BG (2015) Pharmacotherapy handbook (9th ed), McGraw-Hill 3. scientific article databases (www.pubmed.com) |
Course Contribution to Program Qualifications
| Course Contribution to Program Qualifications | |||||||
| No | Program Qualification | Contribution Level | |||||
| 1 | 2 | 3 | 4 | 5 | |||
| 1 | PY-1.Develops, deepens and deepens innovation in the fields of Clinical pharmacy based on master's qualifications with original thought and research at the level of expertise. | X | |||||
| 2 | PY-2.Interdisciplinary interaction with the field is related to; Reaching original results by using knowledge that requires expertise in analyzing, synthesizing and evaluating new and complex ideas. | X | |||||
| 3 | PY-3.Has advanced knowledge about the other technological tools including computer and the devices and tools which are specific to the field at the level required by the field. | ||||||
| 4 | PY-4.Has knowledge about statistical methods. Evaluates and uses new information in the field with a systematic approach. | ||||||
| 5 | PY-5. Has the advanced knowledge of creating patient profiles, patient education, and medication counseling. | X | |||||
| 6 | PY-6.Write the report of the researcher / participant. National / internationally accepted publications are published at scientific meetings. | X | |||||
| 7 | PY-7.Performs necessary examinations using other technological tools including computer and the devices and tools specific to the field at the advanced level as required by the field; Develop new creative solutions to problems. | ||||||
| 8 | PY-8.Develop a new idea, method, design or practice that brings innovation to the field, or researches, designs, adapts and applies a known idea, method, design or application that applies to a different field. | X | |||||
| 9 | PY-9. Uses the knowledge and equipment related to administering medicine to patients and the use of the drug. Gives pharmaceutical care service by providing rational and safe drug use with the duty of observance and supervision. | X | |||||
| 10 | PY-10. Acquires administrative and technical stand-by equipment in the areas where the clinical pharmacy is responsible for and achieves hospital pharmacy practices properly. | X | |||||
| 11 | PY-11.Develop new ideas and methods related to the field by using high level mental processes such as creative and critical thinking, problem solving and decision making. | X | |||||
| 12 | PY-12. Demonstrates embarking on lifelong learning, open for improvement, and continue this behavior. | X | |||||
| 13 | PY-13.Selects the correct statistical methods in the field of health care work and applies and interprets. | ||||||
| 14 | PY-14. Has sufficient consciousness in the field of individual and public health, environmental protection, and job security and applies it. | X | |||||
| 15 | PY-15. Informs relevant persons and institutions in the fields of quality assurance of pharmaceutical products. | ||||||
| 16 | PY-16. Contributes to the solution of scientific, cultural, and ethical problems encountered in the field of clinical pharmacy and corroborates the improvement of these values. Behaves according to the legislation and professional ethics related to duty, right, and responsibilities as an individual. | X | |||||
| 17 | PY-17. Safely documents and keeps track of professional activities and practices. | X | |||||
| 18 | PY-18. Provides information to the patience, healthcare personnel, and society on every drug-related issue. | X | |||||
| 19 | PY-19. Follows and evaluates national and international developments in the field of clinical pharmacy. | X | |||||
| 20 | PY-20.Analyzes statistically to evaluate a scientific article. | ||||||
| 21 | PY-21.Broaden the boundaries of information in the field by publishing at least one scientific article related to the field in national and / or internationally eminent journals. | X | |||||
| 22 | PY-22.Contributes to the advancement of the field by bringing innovation to the field, developing a new idea, method, design or application, or performing an original study independently applying a known idea, method, design or application to a different field. | X | |||||
| 23 | PY-23. Plans, manages, watches the process, and evaluates activities that oriented improvements of employees as part of a project. | X | |||||
Assessment Methods
| Contribution Level | Absolute Evaluation | |
| Rate of Midterm Exam to Success | 50 | |
| Rate of Final Exam to Success | 50 | |
| Total | 100 | |